1. Home
  2. OZ vs ABEO Comparison

OZ vs ABEO Comparison

Compare OZ & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belpointe PREP LLC Units

OZ

Belpointe PREP LLC Units

N/A

Current Price

$52.34

Market Cap

245.7M

Sector

N/A

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$4.91

Market Cap

280.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OZ
ABEO
Founded
2020
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
280.2M
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
OZ
ABEO
Price
$52.34
$4.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$18.75
AVG Volume (30 Days)
11.5K
978.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.74
EPS
N/A
1.35
Revenue
$2,675,000.00
$2,998,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,589.77
P/E Ratio
N/A
$3.71
Revenue Growth
18.68
258.18
52 Week Low
$48.50
$3.93
52 Week High
$75.73
$7.54

Technical Indicators

Market Signals
Indicator
OZ
ABEO
Relative Strength Index (RSI) 56.37 43.97
Support Level $52.02 $4.87
Resistance Level $64.85 $5.60
Average True Range (ATR) 1.05 0.20
MACD 0.48 -0.01
Stochastic Oscillator 85.13 22.97

Price Performance

Historical Comparison
OZ
ABEO

About OZ Belpointe PREP LLC Units

Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: